GSEP
VCYT icon

Golden State Equity Partners’s Veracyte VCYT Stock Holding History

Golden State Equity Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,300
Closed -$106K – 1684
2026
Q1 		$106K Buy
+3,300
New +$122K 0.01% 733

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Golden State Equity Partners's VCYT Position: Q2 2026 in Review

Golden State Equity Partners sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 3,300 shares — an estimated $106K sold.

Golden State Equity Partners first reported a position in VCYT in Q1 2026 and held it in 1 quarter. The position peaked at $106K in Q1 2026. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Golden State Equity Partners reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 3,300 Veracyte shares in Q2 2026, an estimated $106K.
  • Golden State Equity Partners first reported a position in Veracyte in Q1 2026 and held it in 1 quarter.
  • Golden State Equity Partners's Veracyte position peaked at $106K in Q1 2026.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.